Funding history
- $6.7MSeed2026-05-21Source: news.google.com ↗
Founder

Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Co-founders
Investors in Imperagen
Backers from this company's tracked funding rounds.
- PXN Ventures
- IQ Capital
- Northern Gritstone

Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.

Backers from this company's tracked funding rounds.